Blog
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
EQS-Adhoc: Allterco JSCo announces preliminary consolidated sales revenues FY 2022
EQS-Adhoc: Allterco JSCo announces preliminary consolidated sales revenues FY 2022
EQS-News: Baader Helvea Swiss Equities Conference sees a large attendance on its return to being a physical event
EQS-News: Baader Helvea Swiss Equities Conference sees a large attendance on its return to being a physical event
EQS-Adhoc: init innovation in traffic systems SE decides share buyback
EQS-Adhoc: init innovation in traffic systems SE decides share buyback
EQS-News: EPTI AB: EPTI signs new agreement with ModelManagement.com of SEK 17 million
EQS-News: EPTI AB: EPTI signs new agreement with ModelManagement.com of SEK 17 million
EQS-News: Francotyp-Postalia Holding AG: Acquisition of treasury shares – 11th interim report
EQS-News: Francotyp-Postalia Holding AG: Acquisition of treasury shares – 11th interim report
Rights and Issues Investment Trust PLC: NAV-Net Asset Value(s)
Rights and Issues Investment Trust PLC: NAV-Net Asset Value(s)
ENERGISME: Bilan semestriel du contrat de liquidité
ENERGISME: Bilan semestriel du contrat de liquidité
Superdry plc: DSH-Director/PDMR Shareholding*
Superdry plc: DSH-Director/PDMR Shareholding*
Chelverton UK Dividend Trust plc: NAV-Net Asset Value(s)
Chelverton UK Dividend Trust plc: NAV-Net Asset Value(s)
EQS-Adhoc: ATOSS Software AG: Guidance for 2022 outperformed – Revenue Forecast lifted for 2023 - 2025
EQS-Adhoc: ATOSS Software AG: Guidance for 2022 outperformed – Revenue Forecast lifted for 2023 - 2025
EQS-News: SPORTTOTAL appoints Luis Vicente as the chairman of its recently established advisory board
EQS-News: SPORTTOTAL appoints Luis Vicente as the chairman of its recently established advisory board
EQS-News: INDUS Holding AG: INDUS strengthens Infrastructure segment with complementary acquisition
EQS-News: INDUS Holding AG: INDUS strengthens Infrastructure segment with complementary acquisition
EQS-Adhoc: Deutsche Beteiligungs AG: Gross gains and losses on measurement and disposal for the first quarter of the 2022/2023 financial year significantly higher year-on-year
EQS-Adhoc: Deutsche Beteiligungs AG: Gross gains and losses on measurement and disposal for the first quarter of the 2022/2023 financial year significantly higher year-on-year
Nordea Bank Abp: Transaction in Own Shares
Nordea Bank Abp: Transaction in Own Shares
Swiss Re appoints Velina Peneva as Group Chief Investment Officer
Swiss Re appoints Velina Peneva as Group Chief Investment Officer
EQS-News: Energiekontor AG: Energiekontor sells solar park with a generation capacity of some 19 MWp in Brandenburg to CEE Group
EQS-News: Energiekontor AG: Energiekontor sells solar park with a generation capacity of some 19 MWp in Brandenburg to CEE Group
EQS-News: Mynaric reports on Key Performance Indicators for 2022
EQS-News: Mynaric reports on Key Performance Indicators for 2022
EQS-Adhoc: Mynaric reports on Key Performance Indicators for 2022
EQS-Adhoc: Mynaric reports on Key Performance Indicators for 2022
EQS-News: Defence Therapeutics Inc.: DEFENCE ACCUMTM ACCEPTED US PATENT TO BOLSTER ITS VACCINE PLATFORM TECHNOLOGY IP
EQS-News: Defence Therapeutics Inc.: DEFENCE ACCUMTM ACCEPTED US PATENT TO BOLSTER ITS VACCINE PLATFORM TECHNOLOGY IP
Hardman & Co Research on Cornerstone FS (CSFS): Strong FY22 update and Avila House divestment
Hardman & Co Research on Cornerstone FS (CSFS): Strong FY22 update and Avila House divestment
EQS-News: EMX Royalty: Versatile and reliable like a Swiss Army Knife
EQS-News: EMX Royalty: Versatile and reliable like a Swiss Army Knife
EQS-News: BRAIN Biotech AG reports record figures in fiscal year 2021/22 − despite challenging geopolitical environment
EQS-News: BRAIN Biotech AG reports record figures in fiscal year 2021/22 − despite challenging geopolitical environment
Xlife Sciences portfolio company launches project to research a potential therapy for amyotrophic lateral sclerosis (ALS)
Xlife Sciences portfolio company launches project to research a potential therapy for amyotrophic lateral sclerosis (ALS)
EQS-News: Hypoport SE: stable transaction volume for mortgage finance in Q4
EQS-News: Hypoport SE: stable transaction volume for mortgage finance in Q4


